Φορτώνει......
Group B Streptococcus: global incidence and vaccine development
An ongoing public health challenge is to develop vaccines that are effective against infectious diseases that have global relevance. Vaccines against serotypes of group B Streptococcus (GBS) that are prevalent in the United States and Europe are not optimally efficacious against serotypes common to...
Αποθηκεύτηκε σε:
Κύριοι συγγραφείς: | , , , , , , |
---|---|
Μορφή: | Artigo |
Γλώσσα: | Inglês |
Έκδοση: |
2006
|
Θέματα: | |
Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2742968/ https://ncbi.nlm.nih.gov/pubmed/17088932 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrmicro1552 |
Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|